Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Cycle threshold values in symptomatic COVID-19 cases in England.
FUNK, S; ABBOTT, S;
2022
medRxiv (2022). 10.1101/2022.06.13.22276321.
Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations.
SHERRATT, K; Gruson, H; Grah, R; Johnson, H; Niehus, R; Prasse, B; Sandman, F; Deuschel, J; Wolffram, D; ABBOTT, S; Ullrich, A; Gibson, G; Ray, EL; Reich, NG; Sheldon, D; Wang, Y; Wattanachit, N; Wang, L; Trnka, J; Obozinski, G; Sun, T; Thanou, D; Pottier, L; Krymova, E; Barbarossa, MV; ... FUNK, S.
2022
medRxiv (2022). 10.1101/2022.06.16.22276024.
The importance of the generation interval in investigating dynamics and control of new SARS-CoV-2 variants.
Park, SW; Bolker, BM; FUNK, S; Metcalf, CJ E; Weitz, JS; Grenfell, BT; Dushoff, J;
2022
Journal of the Royal Society. Interface, (2022).19 191 10.1098/rsif.2022.0173.
Estimating the contribution of subclinical tuberculosis disease to transmission – an individual patient data analysis from prevalence surveys.
EMERY, J; Dodd, P; Banu, S; Frascella, B; Garden, F; HORTON, K; Hossain, S; Law, I; Van Leth, F; Marks, G; Nguyen, HB; Nguyen, HV; Onozaki, I; Quelapio, MI; RICHARDS, A; SHAIKH, N; Tiemersma, E; WHITE, R; Zaman, K; Cobelens, F; Houben, RM G J;
2022
medRxiv (2022). 10.1101/2022.06.09.22276188.
Heavy-tailed sexual contact networks and the epidemiology of monkeypox outbreak in non-endemic regions, May 2022.
Endo, A; Murayama, H; ABBOTT, S; RATNAYAKE, R; PEARSON, C; EDMUNDS, J; FEARON, E; FUNK, S;
2022
medRxiv (2022). 10.1101/2022.06.13.22276353.
Estimating the duration of antibody positivity and likely time of Leptospira infection using data from a cross-sectional serological study in Fiji.
REES, EM; Lau, CL; Kama, M; Reid, S; LOWE, R; KUCHARSKI, AJ;
2022
PLoS neglected tropical diseases, (2022).16 6 10.1371/journal.pntd.0010506.
Vaccine equity in low and middle income countries: a systematic review and meta-analysis.
Ali, HA; Hartner, A-M; Echeverria-Londono, S; Roth, J; Li, X; ABBAS, K; Portnoy, A; VYNNYCKY, E; Woodruff, K; Ferguson, NM; Toor, J; Gaythorpe, KA;
2022
International Journal for Equity in Health, (2022).21 1 10.1186/s12939-022-01678-5.
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.
MacKenna, B; Kennedy, NA; Mehrkar, A; Rowan, A; Galloway, J; MATTHEWMAN, J; MANSFIELD, KE; Bechman, K; Yates, M; Brown, J; SCHULTZE, A; Norton, S; Walker, AJ; Morton, CE; Harrison, D; BHASKARAN, K; RENTSCH, CT; WILLIAMSON, E; Croker, R; Bacon, S; Hickman, G; Ward, T; Davy, S; Green, A; Fisher, L; ... LANGAN, SM.
2022
The Lancet Rheumatology, (2022).4 7 10.1016/S2665-9913(22)00098-4.
Social mixing patterns relevant to infectious diseases spread by close contact in urban Blantyre, Malawi.
THINDWA, D; Jambo, KC; Ojal, J; MacPherson, P; Dennis Phiri, M; Pinsent, A; Khundi, M; Chiume, L; GALLAGHER, KE; Heyderman, RS; CORBETT, EL; French, N; FLASCHE, S;
2022
Epidemics, (2022).40, 10.1016/j.epidem.2022.100590.
Correction: The local burden of disease during the first wave of the COVID-19 epidemic in England: estimation using different data sources from changing surveillance practices.
NIGHTINGALE, ES; ABBOTT, S; Russell, TW; CMMID Covid-19 Working Group,; LOWE, R; MEDLEY, GF; BRADY, OJ;
2022
BMC PUBLIC HEALTH, (2022).22 1 10.1186/s12889-022-13320-8.